Document is current

Any future updates will be listed below

Development and Characterization of a Neutralizing Anti-idiotype Antibody Against Mirvetuximab for Analysis of Clinical Samples

Crossref DOI link: https://doi.org/10.1208/s12248-017-0098-0

Published Online: 2017-05-22

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark